These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Re: Rufus Cartwright and Linda Cardozo. Transdermal oxybutynin: sticking to the facts. Eur urol 2007;51:907-14. Cornel EB Eur Urol; 2007 Jul; 52(1):286-7; author reply 287. PubMed ID: 17434252 [No Abstract] [Full Text] [Related]
12. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Sand PK; Goldberg RP; Dmochowski RR; McIlwain M; Dahl NV Am J Obstet Gynecol; 2006 Dec; 195(6):1730-5. PubMed ID: 17132474 [TBL] [Abstract][Full Text] [Related]
13. Transdermal oxybutynin for overactive bladder. Davila GW; Starkman JS; Dmochowski RR Urol Clin North Am; 2006 Nov; 33(4):455-63, viii. PubMed ID: 17011381 [TBL] [Abstract][Full Text] [Related]
15. The use of Ditropan in the elderly: nursing responsibilities. Anderson CL Perspectives; 1993; 17(3):11. PubMed ID: 8116314 [No Abstract] [Full Text] [Related]
16. Restoring continence in frail older people living in the community: what factors influence successful treatment outcomes? Harari D; Igbedioh C Age Ageing; 2009 Mar; 38(2):228-33. PubMed ID: 19106253 [No Abstract] [Full Text] [Related]
17. A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth. Corcos J; Casey R; Patrick A; Andreou C; Miceli PC; Reiz JL; Harsanyi Z; Darke AC; BJU Int; 2006 Mar; 97(3):520-7. PubMed ID: 16469019 [TBL] [Abstract][Full Text] [Related]
18. Evolution of transdermal oxybutynin in the treatment of overactive bladder. Sahai A; Mallina R; Dowson C; Larner T; Khan MS Int J Clin Pract; 2008 Jan; 62(1):167-70. PubMed ID: 18173821 [TBL] [Abstract][Full Text] [Related]
19. A meta-analysis comparing trials of antimuscarinic medications funded by industry or not. Tulikangas PK; Ayers A; O'Sullivan DM BJU Int; 2006 Aug; 98(2):377-80. PubMed ID: 16879680 [TBL] [Abstract][Full Text] [Related]
20. The MATRIX study: assessment of health-related quality of life in adults with the use of transdermal oxybutynin. Newman DK Director; 2008; 16(1):22-5. PubMed ID: 19343871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]